Check-Cap Ltd. (CHEK) is a publicly traded Healthcare sector company. As of July 25, 2026, CHEK trades at $1.61 with a market cap of $9.42M and a P/E ratio of 0.00. CHEK moved +2.55% today. Year to date, CHEK is +96.51%; over the trailing twelve months it is flat. Its 52-week range spans $0.56 to $3.13. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces CHEK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CHEK combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.61 |
| Market Cap | $9.42M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.13 |
| 52-Week Low | $0.56 |
| Volume | 58.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
6 analysts cover CHEK: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.